Literature DB >> 10448540

Acetylsalicylic acid in the treatment of headache.

V Limmroth1, Z Katsarava, H C Diener.   

Abstract

Acetylsalicylic acid (ASA) is used to treat a broad range of symptoms and disorders. Since its discovery in 1897, it has been used to treat fever and rheumatic pain, to inhibit the formation of thrombocytes, to prevent myocardial ischemia and strokes, and as preventive medication against neoplasms. ASA is best known, however, as a headache medication. For this function alone, ASA underwent an evolution: from powder to tablet to effervescent and chewable tablets. In addition to these oral formulations, an injectable form was developed in the 1970s for intravenous and intramuscular application. Furthermore, coated (slow-releasing) tablets are now used in the prophylactic treatment of migraine. The various forms of ASA used to treat headache are discussed and the controlled studies conducted to evaluate ASA's efficacy in headache treatment are summarized.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448540     DOI: 10.1046/j.1468-2982.1999.019006545.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

1.  'I saw a great star, most splendid and beautiful': headache in primary care.

Authors:  Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

2.  Racism and general practice--time to grasp the nettle.

Authors:  Gilles de Wildt; Paramjit Gill; Sylvia Chudley; Iona Heath
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

3.  A murky future for academic primary care.

Authors:  John J Frey
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

Review 4.  [Migraine therapy].

Authors:  H-C Diener; V Limmroth
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

5.  Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates.

Authors:  Frederick R Taylor; Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

6.  Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.

Authors:  Christian Lampl; M Voelker; H C Diener
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

7.  Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones.

Authors:  D W Jenkins; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 8.  Headache in primary care: how important is diagnosis to management?

Authors:  Norma O'Flynn; Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

Review 9.  Optimal management of severe nausea and vomiting in migraine: improving patient outcomes.

Authors:  Miguel Ja Láinez; Ana García-Casado; Francisco Gascón
Journal:  Patient Relat Outcome Meas       Date:  2013-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.